| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kevin F Boehnke, J Ryan Scott, Evangelos Litinas, Suzanne Sisley, Daniel J Clauw, Jenna Goesling, David A William. Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain. The journal of pain. vol 20. issue 11. 2020-09-14. PMID:31132510. |
perspective: medical cannabis users with chronic pain show distinct differences in cannabinoid preferences and administration associated with user sex, intentions behind use, and experience with cannabis. |
2020-09-14 |
2023-08-13 |
human |
| Sadhana Dharmapuri, Kathleen Miller, Jonathan D Klei. Marijuana and the Pediatric Population. Pediatrics. vol 146. issue 2. 2020-09-14. PMID:32661188. |
cannabinoids, the psychoactive compounds in marijuana, are one of the most commonly used substances in the united states. |
2020-09-14 |
2023-08-13 |
Not clear |
| Jack Stupinski, Letitia Bible, Samer Asmar, Mohamad Chehab, Molly Douglas, Michael Ditillo, Lynn Gries, Muhammad Khurrum, Bellal Josep. Impact of marijuana on venous thromboembolic events: Cannabinoids cause clots in trauma patients. The journal of trauma and acute care surgery. vol 89. issue 1. 2020-09-09. PMID:32209959. |
impact of marijuana on venous thromboembolic events: cannabinoids cause clots in trauma patients. |
2020-09-09 |
2023-08-13 |
Not clear |
| William S John, Thomas J Martin, Michael A Nade. Cannabinoid Modulation of Food-Cocaine Choice in Male Rhesus Monkeys. The Journal of pharmacology and experimental therapeutics. vol 373. issue 1. 2020-09-08. PMID:31941717. |
marijuana and other cannabinoid compounds are widely used by cocaine users. |
2020-09-08 |
2023-08-13 |
monkey |
| B Kraft, W Strome. [The effects of cannabis and cannabinoids on anesthesia and analgesia during the perioperative period]. Schmerz (Berlin, Germany). vol 34. issue 4. 2020-09-08. PMID:32125500. |
[the effects of cannabis and cannabinoids on anesthesia and analgesia during the perioperative period]. |
2020-09-08 |
2023-08-13 |
Not clear |
| B Kraft, W Strome. [The effects of cannabis and cannabinoids on anesthesia and analgesia during the perioperative period]. Schmerz (Berlin, Germany). vol 34. issue 4. 2020-09-08. PMID:32125500. |
moreover, the use of cannabinoids for medical purposes is also constantly growing and medical cannabis products are legalised by an increasing number of countries. |
2020-09-08 |
2023-08-13 |
Not clear |
| Sabrina L Botsford, Sharon Yang, Tony P Georg. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential. The American journal on addictions. vol 29. issue 1. 2020-09-07. PMID:31577377. |
cannabis and cannabinoids in mood and anxiety disorders: impact on illness onset and course, and assessment of therapeutic potential. |
2020-09-07 |
2023-08-13 |
Not clear |
| Sabrina L Botsford, Sharon Yang, Tony P Georg. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential. The American journal on addictions. vol 29. issue 1. 2020-09-07. PMID:31577377. |
given recent policy changes in favor of cannabis legalization, it is important to understand how cannabis and cannabinoids may impact people with these disorders. |
2020-09-07 |
2023-08-13 |
Not clear |
| Sabrina L Botsford, Sharon Yang, Tony P Georg. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential. The American journal on addictions. vol 29. issue 1. 2020-09-07. PMID:31577377. |
we aimed to assess the effects of cannabis on the onset and course of depression, bipolar disorder, ads, and post-traumatic stress disorder (ptsd), and also to explore the therapeutic potential of cannabis and cannabinoids for these disorders. |
2020-09-07 |
2023-08-13 |
Not clear |
| Samiksha Pandey, Saima Kashif, Mina Youssef, Somia Sarwal, Hala Zraik, Ripudaman Singh, Ian H Rutkofsk. Endocannabinoid system in irritable bowel syndrome and cannabis as a therapy. Complementary therapies in medicine. vol 48. 2020-09-03. PMID:31987224. |
endocannabinoid system in irritable bowel syndrome and cannabis as a therapy. |
2020-09-03 |
2023-08-13 |
Not clear |
| Sumner H Burstei. Eicosanoid mediation of cannabinoid actions. Bioorganic & medicinal chemistry. vol 27. issue 13. 2020-09-01. PMID:31104784. |
the most widely studied cannabinoids so far are tetrahydrocannabinol and cannabidiol. |
2020-09-01 |
2023-08-13 |
Not clear |
| Christopher W Cunningha. Plant-Based Modulators of Endocannabinoid Signaling. Journal of natural products. vol 82. issue 3. 2020-08-31. PMID:30816712. |
extracts from cannabis species have aided the discovery of the endocannabinoid signaling system (ecss) and phytocannabinoids that possess broad therapeutic potential. |
2020-08-31 |
2023-08-13 |
Not clear |
| Ashleigh L Osborne, Nadia Solowij, Ilijana Babic, Jeremy S Lum, Kelly A Newell, Xu-Feng Huang, Katrina Weston-Gree. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 95. 2020-08-26. PMID:31202911. |
effect of cannabidiol on endocannabinoid, glutamatergic and gabaergic signalling markers in male offspring of a maternal immune activation (poly i:c) model relevant to schizophrenia. |
2020-08-26 |
2023-08-13 |
rat |
| Zinah Zamil Al-Ghezi, Philip Brandon Busbee, Hasan Alghetaa, Prakash S Nagarkatti, Mitzi Nagarkatt. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. Brain, behavior, and immunity. vol 82. 2020-08-25. PMID:31356922. |
combination of cannabinoids, delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd), mitigates experimental autoimmune encephalomyelitis (eae) by altering the gut microbiome. |
2020-08-25 |
2023-08-13 |
mouse |
| Zinah Zamil Al-Ghezi, Philip Brandon Busbee, Hasan Alghetaa, Prakash S Nagarkatti, Mitzi Nagarkatt. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. Brain, behavior, and immunity. vol 82. 2020-08-25. PMID:31356922. |
currently, a combination of marijuana cannabinoids including delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) is used as a drug to treat muscle spasticity in patients with multiple sclerosis (ms). |
2020-08-25 |
2023-08-13 |
mouse |
| Jordan J Zager, Iris Lange, Narayanan Srividya, Anthony Smith, B Markus Lang. Gene Networks Underlying Cannabinoid and Terpenoid Accumulation in Cannabis. Plant physiology. vol 180. issue 4. 2020-08-24. PMID:31138625. |
gene networks underlying cannabinoid and terpenoid accumulation in cannabis. |
2020-08-24 |
2023-08-13 |
Not clear |
| Miguel Olivas-Aguirre, Liliana Torres-López, Juan Salvador Valle-Reyes, Arturo Hernández-Cruz, Igor Pottosin, Oxana Dobrovinskay. Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia. Cell death & disease. vol 10. issue 10. 2020-08-21. PMID:31611561. |
anticancer properties of non-psychoactive cannabinoid cannabidiol (cbd) have been demonstrated on tumors of different histogenesis. |
2020-08-21 |
2023-08-13 |
Not clear |
| Kenichi Mishima, Keiichi Iri. [Central Effect of Components of Cannabis: Utility and Risk]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. vol 140. issue 2. 2020-08-17. PMID:32009043. |
cannabis contains over 700 known cannabinoids, terpenoids, flavonoids, and so on; however, the roles and importance of these components have yet to be fully understood. |
2020-08-17 |
2023-08-13 |
Not clear |
| Masahiko Funada, Ken-Ichi Tomiyam. [Dependence and Cytotoxicity of Components of Cannabis]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. vol 140. issue 2. 2020-08-17. PMID:32009044. |
the aim of the present review is to highlight recent knowledge regarding the molecular mechanisms of action and health risks associated with cannabis and synthetic cannabinoid consumption. |
2020-08-17 |
2023-08-13 |
Not clear |
| Jacqueline-Marie N Ferland, Yasmin L Hur. Deconstructing the neurobiology of cannabis use disorder. Nature neuroscience. vol 23. issue 5. 2020-08-14. PMID:32251385. |
cannabinoid receptors, which mediate the actions of cannabis, are abundantly expressed in brain regions known to mediate neural processes underlying reward, cognition, emotional regulation and stress responsivity relevant to addiction vulnerability. |
2020-08-14 |
2023-08-13 |
human |